drugset / Trial / NCT00952276

A Study of Different Formulations of an Adjuvanted A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly

NCT00952276 ↗

Phase 2 Completed 548 enrolled Sanofi
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of the study is to evaluate different doses of the Influenza A/H1N1 pandemic vaccine in adults and the elderly. Primary Objectives: * To describe the immunogenicity of the candidate vaccines after a single injection. * To describe the safety of the candidate vaccines after a single injection.

Timeline

Start
2009-10
Primary completion
2010-12
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Monovalent Subvirion A/H1N1 influenza vaccine Vaccine 0.5 ml Intramuscular
Subject Monovalent Subvirion A/H1N1 influenza vaccine with adjuvant Vaccine 0.5 ml Intramuscular

Indications